Marco De Martino

Marco De Martino

UNVERIFIED PROFILE

Are you Marco De Martino?   Register this Author

Register author
Marco De Martino

Marco De Martino

Publications by authors named "Marco De Martino"

Are you Marco De Martino?   Register this Author

20Publications

260Reads

26Profile Views

Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice.

Lab Anim 2019 Oct 6;53(5):447-458. Epub 2018 Dec 6.

Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0023677218815718DOI Listing
October 2019

Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.

Cancers (Basel) 2019 Sep 4;11(9). Epub 2019 Sep 4.

Istituto di Endocrinologia ed Oncologia Sperimentale-Consiglio Nazionale delle Ricerche (CNR) c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11091302DOI Listing
September 2019

HMGA and Cancer: A Review on Patent Literatures.

Recent Pat Anticancer Drug Discov 2019 Sep 19. Epub 2019 Sep 19.

Istituto di Endocrinologia e Oncologia Sperimentale-CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", via Pansini 5, 80131 Naples. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574892814666190919152001DOI Listing
September 2019

Role of Dicer1 in thyroid cell proliferation and differentiation.

Cell Cycle 2017 9;16(23):2282-2289. Epub 2017 Nov 9.

a Istituto per l'Endocrinologia e l'Oncologia Sperimentale (IEOS) "G. Salvatore", Consiglio Nazionale delle Ricerche (CNR), c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II" , Naples , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2017.1380127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788491PMC
July 2019

HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells.

Cell Cycle 2019 Jul 22;18(13):1446-1457. Epub 2019 May 22.

a Istituto di Endocrinologia ed Oncologia Sperimentale - CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche , Università degli Studi di Napoli "Federico II" , Naples , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2019.1618541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592240PMC
July 2019

New Anti-Cancer Strategies in Testicular Germ Cell Tumors.

Recent Pat Anticancer Drug Discov 2019 ;14(1):53-59

Institute of Endocrinology and Experimental Oncology of the CNR c / o Department of Molecular Medicine and Medical Biotechnology, School of Medicine and Surgery of Naples, University of Naples 'Federico II', Naples, Italy.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/168893/article
Publisher Site
http://dx.doi.org/10.2174/1574892814666190111120023DOI Listing
January 2019

HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.

Histopathology 2018 Jun 9;72(7):1102-1114. Epub 2018 Mar 9.

Programa de Carcinogênese Molecular, Instituto Nacional de Câncer - INCA, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13456DOI Listing
June 2018

UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1.

Genes (Basel) 2018 Mar 29;9(4). Epub 2018 Mar 29.

Programa de Carcinogênese Molecular, Instituto Nacional de Câncer-INCA, Rua Andre Cavalcanti 37, Rio de Janeiro 20231-050, RJ, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes9040188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924530PMC
March 2018

The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.

Genes (Basel) 2017 Nov 17;8(11). Epub 2017 Nov 17.

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli "Federico II", via Pansini, 5, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/genes8110330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704243PMC
November 2017

miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.

BMC Cancer 2017 03 4;17(1):170. Epub 2017 Mar 4.

Istituto di Endocrinologia ed Oncologia Sperimentale "G. Salvatore" - CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3158-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336640PMC
March 2017

HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism.

Sci Rep 2016 11 22;6:37622. Epub 2016 Nov 22.

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli "Federico II", via Pansini 5, 80131 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep37622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118720PMC
November 2016

HMGA1-pseudogenes and cancer.

Oncotarget 2016 May;7(19):28724-35

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli "Federico II", Naples, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053758PMC
http://dx.doi.org/10.18632/oncotarget.7427DOI Listing
May 2016

HMGA1-pseudogene expression is induced in human pituitary tumors.

Cell Cycle 2015 ;14(9):1471-5

a Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche; Scuola di Medicina e Chirurgia di Napoli; Università degli Studi di Napoli "Federico II" , Naples , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2015.1021520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615119PMC
February 2016

miR-130b-3p Upregulation Contributes to the Development of Thyroid Adenomas Targeting CCDC6 Gene.

Eur Thyroid J 2015 Dec 21;4(4):213-21. Epub 2015 Nov 21.

Istituto di Endocrinologia ed Oncologia Sperimentale-CNR, Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli 'Federico II', Naples, Italy; Instituto Nacional de Cancer (INCA), Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000441355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716415PMC
December 2015

HMGA1-pseudogene overexpression contributes to cancer progression.

Cell Cycle 2014 ;13(23):3636-9

a Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli ; Università degli Studi di Napoli "Federico II," ; Naples , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/15384101.2014.974440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613653PMC
September 2015

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.

Oncotarget 2014 Sep;5(18):8341-54

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Scuola di Medicina e Chirurgia di Napoli, Università degli Studi di Napoli "Federico II", Naples, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226687PMC
http://dx.doi.org/10.18632/oncotarget.2202DOI Listing
September 2014